DC Chemicals

All products / DC11512

Acrizanib
CAT. NO. DC11512

Acrizanib

Pack sizes and prices

Pack sizePrice
100 mg$950 USDRequest a quote →
250 mg$1,700 USDRequest a quote →
1 g$3,400 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Acrizanib is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-KDR.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC11512
Product nameAcrizanib
CAS1229453-99-9
Molecular formulaC20H18F3N7O2
Molecular weight445.3978
Purity>98%
SMILESFC(C1=C([H])C(=NN1C([H])([H])[H])N([H])C(N1C([H])=C([H])C2C([H])=C(C([H])=C([H])C1=2)OC1C([H])=C(C([H])([H])N([H])C([H])([H])[H])N=C([H])N=1)=O)(F)F

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Acrizanib (DC11512)

Source references

Rat ocular PK studies with Acrizanib shows a distinctly different profile from that observed with compound 25. While prolonged exposure is once again evident in the PEC, the AUC ratio to the level of Acrizanib in plasma is markedly increased (>21000-fold higher exposure in the PEC than plasma on day 11). Furthermore, unlike 25, Acrizanib also afford much improved retina to plasma AUC exposure ratio after 10 days of dosing (598× for Acrizanib vs 0.8× for 25)[1].

Related research products